s-disease

Documents about s-disease

• Genomic analyses reveal new insights into Alzheimer's disease#290747bioRxiv / medRxiv
• Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab#210694Dipòsit Digital de la Universitat de Barcelona
• Noninvasive Brain Stimulation Techniques and Their Efficacy in Treating Cognition and Memory in Mild Cognitive Impairment and Alzheimer’s Disease—A Systematic Review#231264Europe PMC
• Is Trimethylamine N-oxide a Friend, Foe, or Hormetic Agent in Patients with Parkinson’s Disease: A Focused Review of One Microbial Metabolite#272153BYU ScholarsArchive
• The Impact of Renal Transplant on Coronary Microvascular Function Among Patients With Advanced Chronic Kidney Disease#175004ClinicalTrials.gov
• A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010#6531OpenAlex
• Real-world comparison of brain [<sup>18</sup>F]FDG-PET imaging with CSF Alzheimer's disease biomarkers in a tertiary memory clinic setting#205477Europe PMC
• Nourishing Hearts: The Link Between Food Insecurity and Overall Health Status of Children with Congenital Heart Disease in U.S.#152659bioRxiv / medRxiv
• Amyloid Plaques Ameliorate Memory Deficits and Hippocampal Neuron Loss in an Aβ4-42-Driven Alzheimer's Disease Mouse Model.#193322NCBI PubMed Central
• Acceptability of Technologies to Support Early Dementia Detection: Qualitative Study With the Boston University Alzheimer's Disease Center Cohort.#244213NCBI PubMed Central
• Small molecules to perform big roles : The search for Parkinson's and Huntington's disease therapeutics#270317Repositorio USS
• Freezing of Gait in Parkinson's Disease: A Heterogeneous Phenomenon Across Assessment Tools#273302Europe PMC
• The global scenario of lumpy skin disease, its epidemiological investigation, and prevalence in livestock: A review#5619Europe PMC
• Incidence and Neoplastic Risk Associated with Colonic Stricture in Paediatric-Onset Crohn's Disease: A Population-based Study#137428HAL (France)
• A technical assessment of latent diffusion for Alzheimer's Disease progression.#1353NCBI PubMed Central
• Impacts of host genetics on gut microbiome composition in Alzheimer's disease.#3853NCBI PubMed Central
• Temporal dynamics of cognitive functioning in people with Parkinson's disease#5525Europe PMC
• Peripheral Insulin Resistance and Alzheimer's Disease: Possible Mediators Including Extracellular Vesicles.#8942NCBI PubMed Central
• Classification of Alzheimer’s Disease Using Traditional Classifiers with Pre-Trained CNN#116236PhilArchive
• Neuronal APOE4-induced early hippocampal network hyperexcitability in Alzheimer's disease pathogenesis.#125320NCBI PubMed Central
• TYK2 mediates neuroinflammation in Alzheimer's disease brains with TDP-43 pathology.#150017NCBI PubMed Central
• Deletion of TNFR1 in astrocytes restores memory in aged Alzheimer's disease mice#151547bioRxiv / medRxiv
• Abnormal amyloid PET usually represents intermediate/high Alzheimer's disease neuropathologic change.#161815NCBI PubMed Central
• Prospective Phenotyping of Autonomous Aldosterone Secretion#165944ClinicalTrials.gov
• Privacy-by-Design with Federated Learning will drive future Rare Disease Research.#182480NCBI PubMed Central
• Graph-Based Biomarker Discovery and Interpretation for Alzheimer's Disease#183173arXiv (OAI)
• Advancing RNA base editing treatments for inherited retinal disease#193885Ora Oxford University Research
• Pre-beta burst dynamics in Parkinson’s disease: distinguishing signal from artifact#203153PMC Full-Text (OAI)
• How does type 2 diabetes modify the risk of Alzheimer's disease?#209321NCBI PubMed Central
• Hippocampal subregional texture features associated with Alzheimer’s disease severity and cognition.#209470NCBI PubMed Central
• Robust transcriptomic signatures of Alzheimer's disease progression: validated explainable AI approach.#213872NCBI PubMed Central
• Reduced ULK1 links impaired autophagy and mitophagy to Alzheimer's disease pathology.#218811NCBI PubMed Central
• Nonmotor Symptoms in Parkinson's Disease: Neurophysiology Biomarkers and Neuromodulation Approaches.#218859NCBI PubMed Central
• Cell-based regenerative interventions in Parkinson's disease: Overcoming pharmacological limitations.#223036NCBI PubMed Central
• Region-Specific Brain Atrophy Across Alzheimer’s Disease Stages in the NACC Dataset#225155OSF
• Clinical, cognitive and neuropsychiatric correlates of personality in Wilson's disease.#227658NCBI PubMed Central
• The relationship between personality traits and Alzheimer’s disease: a narrative review.#263149NCBI PubMed Central
• Mechanisms of increased Alzheimer's Disease pathology with R47H and R62H TREM2 variants#264596bioRxiv / medRxiv
• Regulation between LRRK2 and PP2A signaling in cellular models of Parkinsons disease#267877bioRxiv / medRxiv
• Tanycytic degeneration impairs tau clearance and contributes to Alzheimer’s disease pathology#268584HAL (France)
• Amyloidosis of bridging veins is a pathologic feature of Alzheimer's disease.#269427NCBI PubMed Central
• Atrophy signature for alpha-synuclein copathology in Alzheimer's disease.#269580NCBI PubMed Central
• Rewiring mTOR signaling in Alzheimer's disease: emerging mTOR modulators beyond oncology.#275382NCBI PubMed Central
• Comparative evaluation of oxidative stress biomarkers F2-isoprostanes and 8-OHdG in Parkinson's disease and Type 2 Diabetes Mellitus: a systematic review and meta-analysis of human studies#123333Europe PMC
• Reduced repressive epigenetic marks, increased DNA damage and Alzheimer's disease hallmarks in the brain of humans and mice exposed to particulate urban air pollution#251777Repositorio UNAB
• Table 1_Ershiwuwei Shanhu Pill ameliorates cognitive impairment in Alzheimer’s disease mice by remodeling gut microbiota and host serum metabolites.xls#291333Figshare
• Associations between frailty, biomarkers of cerebral pathology, cognitive and neuropsychiatric symptoms: a memory clinic study#15454HAL (France)
• Current status of 5-aminosalicylic acid in Crohn’s disease treatment: a nationwide survey and analysis of perspectives and practice patterns among inflammatory bowel disease physicians.#174802NCBI PubMed Central
• Clinical impact of the Alzheimer's Disease Neuroimaging Initiative: A review of studies using ADNI data (2023 to June 2025).#28212NCBI PubMed Central
• Monoaminergic Networks of Cognitive and Behavioral Symptoms in Early Parkinson's Disease.#1345NCBI PubMed Central